Human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) entails the prompt administration of antiretroviral agents following potential exposure to prevent viral acquisition. Clinical ...
Pharmacy students in the U.S. show limited knowledge of HIV prophylaxis, especially PEP, due to inadequate assessment tools. Pharmacists are pivotal in HIV prevention, but their knowledge of PrEP and ...
Single-tablet therapy for HIV Researchers evaluated adherence to nonoccupational post-exposure prophylaxis following potential HIV exposure. A single-tablet regimen consisting of DOR/3TC/TDF for ...
Persons initiating nPEP should be informed that preexposure prophylaxis (PrEP) can reduce their risk for acquiring HIV in the case of repeat or continuing exposure after the nPEP course. HealthDay ...
On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of ...
Low PrEP uptake is slowing France’s HIV prevention goals, with major gaps in access for key groups. Learn more.
Rough Draft Atlanta on MSN
Emory University joins national coalition to advance HIV services in community pharmacies
Rx for Change is a national coalition to advance HIV services in community pharmacies including testing and prevention. The ...
Among individuals using HIV pre-exposure prophylaxis (HIV PrEP), doxycycline post-exposure prophylaxis (doxyPEP) was associated with a substantial decline in chlamydia and syphilis incidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results